NCT00398723View on ClinicalTrials.gov

Narrowband UVB Treatment in Patients With Vitiligo

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Vitiligo
Interventions
DEVICE

Narrowband UVB

Treatment three to seven times weekly for a total of 12 to 26 weeks (36 to 168 treatments). Dosing of NB-UVB will begin at 100-280 mJ/cm2, depending on tolerance and skin type, and will be titrated 10-20% per session until clinical efficacy or symptomatic erythema

Trial Locations (1)

10021

Rockefeller University Hospital, New York

All Listed Sponsors
lead

Mary Sullivan-Whalen

OTHER

NCT00398723 - Narrowband UVB Treatment in Patients With Vitiligo | Biotech Hunter | Biotech Hunter